Pediatric Pipeline Update: Key Approvals and Label Expansions You May Have Missed in 2026 Dermatology Times Source link
Johnson & Johnson Stock (JNJ) Update: Shares Hold Near $208 as Markets Close for the Weekend; Eczema Trial Halt, Pipeline Wins, and 2026 Outlook in Focus ts2.tech Source link
Eczema Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution The Globe and Mail Source link
The skinny on eczema: Lots of new treatments OK’d or in pipeline Vero News Source link